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Costello syndrome is a rare syndrome associated with de novo mutations in the HRAS gene. It is mostly revealed
during in the first months of life by growth retardation, facial dysmorphic features, skin and cardiac abnormalities and
subsequent cognitive deficit of varying severity. We report a case of Costello syndrome in a 3-month-old infant. The
initial cardiac investigations were normal except frequent premature atrial complexes. After few months, worsening
arrhythmia with bursts of ventricular tachycardia were noted as well as the secondary progressive obstructive left
ventricular hypertrophic cardiomyopathy (HCM).
Cardiac involvement is determinant for the prognosis of Costello syndrome. It frequently consists of hypertro-
phic cardiomyopathy (one third of patients), with involvement of the left ventricle in half of the cases. It is often
asymmetrical and associated with obstruction of the outflow recalling family hypertrophic cardiomyopathy. The nat-
ural history of HCM in Costello syndrome and its management remains poorly known because of paucity of
reported cases. Progression of the HCM can be very rapid like the reported case. On the other hand, the spontaneous
regression of the HCM in some patients has been reported. In addition, cardiac threatening arrhythmias may be
noted. So that, cardiac assessment and monitoring with regular echocardiography and electrocardiogram follow
up is mandatory.
 2013 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.Introduction
Costello syndrome is a rare syndrome associ-ated with de novo mutations in the HRAS
gene. The prevalence of this syndrome is un-
known, but about 250 cases have been reported
in the literature [1]. We report the case of an infant
with Costello syndrome with severe cardiac
events and we present a brief review of literature
on the characteristics of cardiac involvement in
this syndrome.Observation
We report the case of a 03 month old male in-
fant. His parents were concerned about swallow-
ing disorders with loss of weight of 900 g in
1 month. The medical history revealed severe
hydramnios, macrosomia with a birth weight of
4700 g and neonatal hypoglycemia and hypocalce-
mia. The infant had a weight of 4300 g at his first
presentation. Physical examination revealed facial
dysmorphism suggestive of Costello syndrome
with macrocephaly (head circumference of
Figure 1. Dysmorphic features suggestive of Costello’s syndrome.
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tened nose, low-set ears, macroglossia and short
neck (Fig. 1). The infant also had skin abnormali-
ties and hair and nail characteristics of Costello
syndrome: Cutis laxa (Figs. 2a and b), deep folds
of the palms and soles (Fig. 3a and b), laxity of
small joints of the hand and axial hypotonia.Figure 2. (A and B) : C
Figure 3. (A and B): Deep skin folds at thPsychomotor development and growth of our pa-
tient were marked by poor gain of weight, short
stature, delayed psychomotor acquisitions and
poor coordination sucking – swallowing.A genetic study confirmed the diagnosis of Costello
syndrome
On cardiovascular routine examination, the
heart rate was around 140 beats per min. Blood
pressure was 80/40 mmHg and cardiac ausculta-
tion was normal. The femoral pulses were well felt
and there was no sign of heart failure. The electro-
cardiogram showed a regular sinus rhythm with
some premature ventricular contractions (PVCs).
The initial echocardiogram was normal. In partic-
ular, there was no evidence for a cardiomyopathy
or septal defect and the heart valves were thin and
healthy. The ECG Holter monitoring showed fre-
quent PVCs sometimes in doublets associated to
few bursts of premature atrial complexes. The in-
fant was then started on beta blockers and close
monitoring was recommended.utis Laxa features.
e soles of the feet (A) and palms (B).
Figure 4. Repetitive premature ventricular complexes.
Figure 5. Apical view showing moderate mitral regurgitation and
acceleration of the flow over the sub aortic region.
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showed an asymmetric non obstructive hypertro-
phic cardiomyopathy involving especially the ba-
sal part of the ventricular septum measured at
9 mm. There was no left ventricular outflow
obstruction or mitral regurgitation. Left ventricu-
lar function was preserved and pulmonary pres-
sures were normal. The ECG Holter monitoring
objectified repetitive PVCs in doublets and triplets
with ventricular tachycardia bursts (Fig. 4). Wedecided to add amiodarone to the beta blocker
treatment.
The evolution was marked by the disappearance
of ventricular tachycardia bursts, and a scarcity of
PVCs. The infant was asymptomatic cardiac wise
and swallowing disorders are relatively improved,
thanks to a rehabilitation of swallowing. However,
echocardiographic assessment done three months
later showed a worsening of HCM with septal
thickness of 10 mm, thickened mitral valve with
onset of moderate mitral regurgitation, as well as
a left ventricular outflow tract obstruction with a
peak gradient of 40 mmHg measured 2 months
later at 64 mmHg (Figs. 5 and 6).Discussion
Costello syndrome was first described in 1971 by
Costello [2]. The gene responsible for this syn-
drome is the HRAS gene [3]. Diagnosis is mainly
clinical. In the series published by Lin and al
about 61 genetically confirmed cases of Costello
syndrome, the average age at diagnosis was
4.2 years. The diagnosis was made before the age
of 1 year in one third of cases [4]. Clinical presen-
tation consists on facial dysmorphism, growth
retardation associated with severe psychomotor
retardation and feeding difficulties [5]. A notion
of polyhydramnios during pregnancy, macroso-
mia and neonatal hypoglycemia are often found
[6]. Prognosis is dependent on frequent develop-
Figure 6. Peak gradient of 64 mm Hg over the left ventricular outflow tract.
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roblastoma on one hand and on the cardiac
involvement on the other hand [4]. The most com-
mon reported heart lesions are pulmonary steno-
sis, hypertrophic cardiomyopathy, cardiac
arrhythmias, atrial or ventricular septal defects
(44%) and congenital mitral valve abnormalities
[7]. Dysmorphia and cardiac involvement of Cos-
tello syndrome are similar to those of Noonan
syndrome, cardio-facial-cutaneous syndrome
(CFC) and LEOPARD syndrome. These syn-
dromes are due to mutations in genes that encode
proteins involved in the intracellular cascade of
RAS/mitogen-activated protein kinase (MAPK).
They are also called ‘‘RASopathies’’ [3].
The prevalence of HCM in Costello syndrome
varies from 20% to 61% depending on the series
[4,7]. In the series of Swiwik et al. [7], the age of
discovery of the HCM ranged from 5 months to
20 years. Similarly, Lin et al. [4] noticed that the
diagnosis of HCM is not always done at birth. In-
deed, some patients develop HCM later, as is the
case of our patient. This could be related to myo-
cardial accumulation of metabolites over time [8].
Regular echocardiographic monitoring is neces-
sary because for the possibility of rapidly evolving
forms of HCM as in the case of our patient.
HCM in Costello syndrome is similar to familial
forms of HCM. Symptoms usually described are
dyspnea, angina, syncope, arrhythmias and sud-
den death. The hypertrophy of basal part of the
ventricular septum is the most common [9]. Se-
vere hypertrophy and left ventricular out flow
obstruction and may be cause of dyspnea or angi-
na on exertion. Life-threatening ventricular
arrhythmias are possible.At histological analysis, hypertrophy, myocyte
disorganization and fibrosis, which represent the
anatomical substrate of ventricular arrhythmias,
were identified in the HCMCostello syndrome [8].
Resolution or significant spontaneous regres-
sion of the septal hypertrophy has been inter-
preted as a phenomenon of widespread
remodeling leading to raise the hypothesis that
the HCM associated with Costello syndrome is
not a static disease [4]. Moreover, a rapidly fatal
evolution with a rapid enhancement of the left
ventricular gradient and occurrence of heart fail-
ure signs has been reported in the literature [10].
To improve the quality of life of these patients,
medical intervention and / or surgery may be nec-
essary to reduce the degree of obstruction and re-
duce complications such as arrhythmias [11].
Supraventricular tachycardia, especially atrial
tachycardia is frequently associated with Costello
syndrome (up to one third of patients). The first
cases of Costello syndrome associated to supra-
ventricular rhythm disturbances have been re-
ported in 1993 [12]. Then Siwik et al. [7]
described the cardiac manifestations of Costello
syndrome in 30 patients, 18% had tachyarrhyth-
mias. It was ectopic atrial tachycardia, supraven-
tricular tachycardia of unspecified mechanism
and a case of flutter. In the series published by
Lin et al. [13], one third of children had arrhyth-
mias, 74% in type of atrial tachycardia. The other
children had ventricular arrhythmias in type of
premature ventricular complexes or well tolerated
neonatal ventricular tachycardia. Our infant had
impaired ventricular excitability with bursts of
ventricular tachycardia, which have well resolved
on anti arrhythmia drugs.
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Costello syndrome is a rare genetic syndrome.
Clinical expertise and molecular study allow the
diagnosis of this disease. Cardiac involvement,
particularly hypertrophic cardiomyopathy and
rhythm disorders, alters the prognosis. Their pos-
sible rapidly fatal progression imposes a close car-
diac rhythm monitoring and echocardiography
follow up.
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